Probiotics for hepatic encephalopathy

In this open label trial, 235 patients with a history of hepatic encephalopathy were randomized to placebo, lactulose tid, or probiotics tid. Within 12 months of follow up, hepatic encephalopathy developed in 38 placebo patients, 22 probiotic patients, and 18 lactulose patients. Although a small trial, this suggests that probiotics may be added to the options for secondary prevention of hepatic encephalopathy (abstract)

Danielle Scheurer

Dr. Scheurer is a clinical hospitalist and the Medical Director of Quality and Safety at the Medical University of South Carolina in Charleston, South Carolina, and is Assistant Professor of Medicine. She is a graduate of the University of Tennessee College of Medicine, completed her residency at Duke University, and completed her Masters in Clinical Research at the Medical University of South Carolina. She also serves as the Web Editor and Physician Advisor for the Society of Hospital Medicine.

Leave a Comment